Search results
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks· 7 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved non-inferior vaccine efficacy against COVID-19 when compared ...
Long Covid expert: all infections have "prolonged consequences"
Boing Boing· 2 days agoA recent analysis by Bloomberg and Airfinity revealed that at least 13 communicable...
Long COVID: Will a new 'consensus definition' help improve care?
Medical News Today· 3 days agoThe NASEM consensus definition is: “Long COVID (LC) is an infection-associated chronic condition...
The First Three Months
The Atlantic· 6 days agoA reporter calling me at home on a holiday about a possible disease outbreak was concerning, but not that unusual. The press sometimes had better, or at...
Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines | Investing.com
Investing.com· 5 days agoStocks Analysis by MarketBeat.com (Jea Yu) covering: Merck & Company Inc, Amgen Inc, Biogen Inc,...
The COVID KP.3 Variant Makes Up 25% of U.S. Cases: Can Rapid Tests Detect It?
AOL· 16 hours agoExperts said there’s no reason to believe KP.3 is causing any new symptoms of SARS-CoV-2, the virus that causes COVID. COVID cases have ...
They recommend strengthening immunity against Covid-19 in people with cancer
Hardwood Paroxysm· 3 days agoThis is one of the conclusions of a study on the effectiveness of vaccines against Covid in cancer...
Dr. Anthony Fauci on pandemics, partisan critics, and "the psyche of the country"
CBS News· 6 days agoGrowing up on 13th Avenue in Dyker Heights, Brooklyn, in the 1940s and '50s, Anthony "Tony" Fauci...
SF wastewater levels show spike in COVID-19
The San Francisco Examiner· 4 days ago“In summer 2023, we saw wastewater concentrations for SARS-CoV-2 start to increase in mid-June and peak during August,” she told The ...
New study involving nearly 185,000 patients recommends strengthening immunity against COVID-19 in...
Medical Xpress· 3 days agoThe research, published in the journal Nature Communications, recommends administering additional doses of the vaccine among this risk population. Cancer patients are at increased ...